Patents Assigned to BHN Co., Ltd.
  • Method for angiogenesis inhibition or immunostimulation
    Patent number: 7977379
    Abstract: The present invention relates to a composition for use in prevention or treatment of a vascular-related disease, particularly used for angiogenesis inhibition, tumor growth inhibition or tumor metastasis inhibition, or immunostimulation, which comprises glutamic acid or derivatives thereof, preferably glutamic acid is anhydrous glutamic acid represented by Formula (1) or pyroglutamic acid, and a pharmaceutically acceptable carrier or an edible carrier, and a method of preventing or treating a vascular-related disease.
    Type: Grant
    Filed: May 15, 2003
    Date of Patent: July 12, 2011
    Assignee: BHN Co., Ltd.
    Inventors: Takashi Kouge, Akihiro Yamashita, Keno Ishihara